Skip to main content
  • 487 Accesses

5. Conclusions

Epicardial transplantation of skeletal myoblasts in conjunction with a CABG or LVAD procedure is feasible and safe, and it does not appear that 116 Edward B. Diethrich cell transplantation poses a substantial risk of life-threatening arrhythmia in this small evaluation. Further study of the efficacy of myoblast transplantation is warranted, and we are now involved in investigations of catheterbased delivery systems and imaging protocols that support percutaneous skeletal myoblast transplantation (as described in “Percutaneous Myoblast Transplantation”, chapter 14 of this text).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

6. References

  1. American Heart Association. AHA Heart and Stroke Statistics-2004 Update.

    Google Scholar 

  2. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation, Nat. Med. 4, 929–1033 (1998).

    Google Scholar 

  3. Dib N, Diethrich EB, Campbell A, et al. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction, J. Endovasc. Ther. 9, 313–19 (2002).

    Article  Google Scholar 

  4. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure, Lancet 357, 279–80 (2001).

    Article  Google Scholar 

  5. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction, J. Am. Coll. Cardiol. 41, 1078–83 (2003).

    Article  Google Scholar 

  6. Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal-muscle-derived stem cells in patients with non-acute myocardial infarction, E. Heart J. 24, 2012–20 (2003).

    Google Scholar 

  7. Smits PC, van Geuns RJM, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure, J. Am. Coll. Cardiol. 42, 2063–69 (2003).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Diethrich, E.B. (2006). Skeletal Myoblasts: The U.S. Experience. In: Dib, N., Taylor, D.A., Diethrich, E.B. (eds) Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair. Springer, Boston, MA. https://doi.org/10.1007/0-387-30939-X_7

Download citation

  • DOI: https://doi.org/10.1007/0-387-30939-X_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-25788-4

  • Online ISBN: 978-0-387-30939-2

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics